|
|
||||||||
1 Quebec Heart Institute and Department of Medicine, Faculty of Medicine, Laval University, Ste-Foy, Quebec G1K 7P4; and 2 Laboratory of Molecular Endocrinology, Centre Hospitalier de l'Université Laval, Ste-Foy, Quebec, Canada G1V 4G2
Estrogen replacement
therapy reduces risk of cardiovascular events by altering coronary
vasoregulation and distribution of blood flow. Vessel reactivity and
blood flow distribution were assessed in anesthetized female rabbits in
the following groups: 1) sham, 2) ovariectomy,
3) ovariectomy + 17
-estradiol, and
4) ovariectomy + dehydroepiandrosterone. After a
2-wk treatment, cardiac hemodynamics, vascular reserve, and blood
flow were evaluated during the following infusions: 1) NaCl,
or vehicle (0.5 ml/min), 2) acetylcholine (2 mg/kg),
3) isoproterenol (2 mg · kg
1 · min
1), and
4) chromonar (8 mg/kg). In hearts from ovariectomized
rabbits, autoregulatory blood flow was preserved despite lower
diastolic perfusion pressures (55 ± 8 vs. 64 ± 8 mmHg
in sham) and rate-pressure product (14.4 ± 0.8 vs. 19.3 ± 0.8 beats/min · mmHg×10
3). Estrogen
replacement therapy restored coronary pressure and reserve, and all
drugs increased vascular conductance. In conclusion, in hearts from
ovariectomized rabbits, vascular reserve declined because coronary
pressure was lower; however, blood flow was preserved at a higher level
than expected for oxygen demand. Estrogen replacement therapy restores
myocardial oxygen supply-demand indices and returns coronary
pressure-flow data to levels observed in animals with intact ovaries.
ovariectomy; vasoregulation
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |